In pursuance of Regulation 33(3) (C) of the LODR, Bharat Immunologicals & Biologicals Corporation has informed about the submission of Limited Review Report along with the financial results for the Quarter ended 30th September 2018.
The above information is a part of company’s filings submitted to BSE.